Literature DB >> 23657617

[Vertebral osteomyelitis].

N Jung1, H Seifert, J Siewe, G Fätkenheuer.   

Abstract

Infections of the vertebra and neighboring disc create the characteristic lesions of vertebral osteomyelitis. The incidence has been estimated to range from 0.3 to 6.5 cases/100,000 persons. The hematogenous route of infection is predominant while direct inoculation through iatrogenic procedures and contiguous spread from adjacent tissue are rare. Most patients with hematogenous vertebral osteomyelitis exhibit predisposing factors, such as advanced age and diabetes mellitus. Diagnosis is often delayed due to the nonspecific nature of back pain, the main symptom. Furthermore, fever is frequently absent. Staphylococcus aureus is the most prevalent pathogen of pyogenic vertebral osteomyelitis in Europe. Magnetic resonance imaging (MRI) is the method of choice for the radiological diagnosis and blood cultures belong to the standard procedures. In cases of negative blood cultures a biopsy is generally warranted for microbiological diagnosis, either by computed tomography (CT)-guided needle biopsy or open surgery. Randomized trials that have addressed different antibiotic regimens are lacking. The recommended duration of treatment ranges from 6 weeks to 3 months. Patients with abscesses and implant devices in particular should be treated for 3 months.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23657617     DOI: 10.1007/s00108-012-3142-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  Clinical practice. Vertebral osteomyelitis.

Authors:  Werner Zimmerli
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

Review 2.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

3.  Spontaneous pyogenic vertebral osteomyelitis and endocarditis: incidence, risk factors, and outcome.

Authors:  Carlos Pigrau; Benito Almirante; Xavier Flores; Vicenç Falco; Dolors Rodríguez; Isabel Gasser; Carlos Villanueva; Albert Pahissa
Journal:  Am J Med       Date:  2005-11       Impact factor: 4.965

4.  Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals.

Authors:  Martin C McHenry; Kirk A Easley; Geri A Locker
Journal:  Clin Infect Dis       Date:  2002-04-22       Impact factor: 9.079

5.  Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposure.

Authors:  Chung-Jong Kim; Kyoung-Ho Song; Wan Beom Park; Eu Suk Kim; Sang Won Park; Hong-Bin Kim; Myoung-don Oh; Nam Joong Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

6.  A seven-year prospective study on spondylodiscitis: epidemiological and microbiological features.

Authors:  C D'Agostino; L Scorzolini; A P Massetti; M Carnevalini; G d'Ettorre; M Venditti; V Vullo; G B Orsi
Journal:  Infection       Date:  2010-02-27       Impact factor: 3.553

7.  Bacteremic Staphylococcus aureus spondylitis.

Authors:  A G Jensen; F Espersen; P Skinhøj; N Frimodt-Møller
Journal:  Arch Intern Med       Date:  1998-03-09

Review 8.  Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome.

Authors:  E M Trecarichi; E Di Meco; V Mazzotta; M Fantoni
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-04       Impact factor: 3.507

9.  Vertebral osteomyelitis: assessment using MR.

Authors:  M T Modic; D H Feiglin; D W Piraino; F Boumphrey; M A Weinstein; P M Duchesneau; S Rehm
Journal:  Radiology       Date:  1985-10       Impact factor: 11.105

10.  Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003.

Authors:  L Grammatico; S Baron; E Rusch; B Lepage; N Surer; J C Desenclos; J M Besnier
Journal:  Epidemiol Infect       Date:  2007-06-14       Impact factor: 2.451

View more
  6 in total

1.  [Chameleon spondylodiscitis : Challenge for geriatricians].

Authors:  Werner Hofmann
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

2.  Spondylodiscitis: Diagnosis and Treatment Options.

Authors:  Christian Herren; Norma Jung; Miguel Pishnamaz; Marianne Breuninger; Jan Siewe; Rolf Sobottke
Journal:  Dtsch Arztebl Int       Date:  2017-12-25       Impact factor: 5.594

Review 3.  [Septic arthritis and spondylodiscitis : Rare but feared diseases].

Authors:  N Jung; S Vossen
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

4.  [Chameleon spondylodiscitis : Challenge for geriatricians].

Authors:  Werner Hofmann
Journal:  Z Gerontol Geriatr       Date:  2017-10-10       Impact factor: 1.281

5.  Prevotella osteomyelitis after dental capping procedure.

Authors:  Alexander Williams; Thomas Kerkering
Journal:  IDCases       Date:  2017-02-07

6.  Antibiotic-loaded calcium sulfate beads in spinal surgery for patients with spondylodiscitis: a clinical retrospective study.

Authors:  Xiaojie Tang; Jianyi Li; Chunxiao Wang; Fang Liu; Jianwei Guo; Jiangwei Tan; Qinyong Song; Haifei Cao; Yao Zhang
Journal:  BMC Musculoskelet Disord       Date:  2022-03-19       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.